“a positive trend”

In a study by Isolauri and colleagues involving 45 infants with 9 months of follow-up, growth rates were higher for AAF, with a significant increase in height ( p = 0.006) and a positive trend in weight gain ( p = 0.09) compared with EHF.

While correlation of proportion of cells rotating with the proximal cues with lesion size did show a positive trend (Figure 11b ), this did not reach significance (Spearman's correlation: r (7) = 0.700, p = .090).

There was a positive trend with the effect of age, with villus area increasing by 25% and 35% for both insoluble and soluble diets, respectively ( p < 0.09). 3.3.

In asymptomatic MCs, BAG was positively correlated with plasma NfL ( r = 0.17, p = 0.03), but showed a positive trend in relation to CSF NfL (CSF r = 0.14, p = 0.09).

Correlation between foal age in hours and SI was not significant but had a positive trend (r = 0.512; p = 0.091) ( Fig 3 ).

It also showed a positive trend to insoluble collagen fraction (r=0.26, P =0.091).

The path from changes in PTSD to changes in appetitive aggression indicated a positive trend ( p = .091), but a non-significant one.

NN1 did not significantly perform better than kNN; however, it presented a positive trend in the unimodal PRV case (PRV: P =.091).

No difference in PFS (4.2 versus 4.6 months for EB and PGB, respectively) and only a positive trend for OS (17.0 versus 10.0 months, for EB and PGB, respectively; HR 0.45, 95% CI: 0.18–1.16, P = 0.092) were observed.

Colleague support: Although a positive trend was observed ( β = 0.095), it did not reach statistical significance ( t = 1.690, p = 0.092).

In addition, there is a positive trend between the SF and inflammation activity with the exception of 1 point (p = 0.093, Figure 2B ).

Between-group differences in change of the WMFT score with respect to baseline showed a positive trend at post-training (.36 (SE .21), t (54.67) = 1.71, P = .093) and significance at 3 months ( t (55.00) = 2.82, P = .0067) with an estimated difference of .63 (SE .22) points average change per item from baseline ( Figure 4 ).

The idiopathic DCM group showed a significant reduction of LVEDD ( p = 0.017, CI 0.5–4.3), but LVEDV and LVESV did not decrease significantly despite showing a positive trend ( p = 0.093, CI −4 to 46 and p = 0.073, CI −2 to 43).

The frequent use of plastic food containers was significantly associated with urinary mEHP (p = 0.026), and a positive trend was noticed for mEHP in amniotic fluid (p = 0.093).

Modified Rankin score (mRS) vs dice A positive trend (coef = 0.022, p = 0.093) was noted in meta-regression between functional disability (mRS) and segmentation accuracy.

A positive trend was also observed in anti-Müllerian hormone concentration by 1.053 mg/l (p=0.093), though statistically insignificant.

For trafficking markers ( Figure 3 ), α4β7 did show a positive trend with viral load (R = 0.3758, p = 0.0932; Figure 3 A), while only CCR7 significantly correlated with viral load (R = 0.4804, p = 0.0275; Figure 3 B).

Lifetime concentrations showed a positive trend ( ρ = 0.329; p = 0.094).

In children and adolescents, a positive trend was observed for total psychotropics (ρ = 0.25; p = 0.094) and a significant correlation for antidepressants (ρ = 0.40; p = 0.006) (Table S3 ).

PSS showed a positive trend toward greater JOA improvement (β = 0.38, p = 0.094), as did BMI (β = 0.14, p = 0.094), although neither reached statistical significance.

For the muscle strength and endurance measurements, the E-Fit group showed a positive trend in the isometric curl-up test when compared to the control group between the 6- to 12-month follow-ups ( p = 0.095), but the difference was not sustained at the 12-month follow-up. 3.3.

Of 91 patients, 28 had an overexpression of MICA/B, associated with a significant recurrence-free survival ( p = 0.037) but with only a positive trend of OS ( p = 0.095).

In a previous Phase 3 FM study, treatment with TNX‐102 SL 2.8 mg showed clinically meaningful efficacy across most secondary and sensitivity analyses, and the study's primary efficacy endpoint (30% responder analysis) showed a positive trend ( P = 0.095) but was not statistically significant. 15 Based on these results, we expected that a higher dose of TNX‐102 SL (i.e., 5.6 mg) would have the potential to establish substantial evidence of efficacy and maintain an acceptable safety and tolerability profile in patients with FM.

There was also a positive trend towards how well they thought that the BlackBox training facilitated their MIST-performance (RSquare=0.10; P=0.0953).

Androgen receptor (AR) expression showed a positive trend with the resorption marker CTX-I ( p = 0.0956).